ADM Deerland Probiotics & Enzymes is a biotechnology company based in Kennesaw, Georgia. Since its establishment in 1990, the company has been specializing in customized enzyme and probiotic-based formulations. Their approach, motivated by science and measured by wellness, sets them apart in the Health Care and Manufacturing industries. Deerland collaborates with customers to develop innovative and proprietary solutions tailored to their specific needs. They also offer a line of clinically studied branded products, including the probiotic strain DE111® and the novel prebiotic PreforPro®. Notably, the company provides regulatory support and performs specialty contract manufacturing services, covering a wide range of products such as bulk blends, liquids, hard shell capsules, and tablets, as well as bottling and labeling. Moreover, the company secured their Venture Round investment on 21 June 2017 with RoundTable Healthcare Partners as the lead investor. This capital injection is a testament to the industry's confidence in ADM Deerland Probiotics & Enzymes and their potential for further growth and innovation in the biotechnology and health care sectors. For more information, interested parties can contact them at 800.697.8179 or visit their website at www.Deerland.com.
No recent news or press coverage available for ADM Deerland Probiotics & Enzymes.